Compare Ascendis Pharma A/S (ASND) vs Elastic NV (ESTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Elastic NV — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Elastic NV trades at $75.26 (market cap $7.94B). The key difference: Ascendis Pharma A/S is far larger — about 2.1× Elastic NV's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Elastic NV nearer its low. Which is the better fit depends on your goals.
| ASND | ESTC | |
|---|---|---|
Market Cap | $16.67B | $7.94B |
Sector | Health | Technology |
52-Week High | $277.18 | $94.47 |
52-Week Low | $189.74 | $43.30 |
Enterprise Value | $17.04B | $7.16B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →
